Texas A&M Football

SECMD25: Alabama, Mississippi State, Florida & Oklahoma headline Day 3

Wednesday at SEC Media Days brings representatives from Alabama, Mississippi State, Florida and Oklahoma to the College Football Hall of Fame. Each head coach and three player representatives for each school took to the stage on Day 3 in Atlanta.
By TexAgs
July 16, 2025
3.8k Views
Discuss
Story Poster
Photo by Gary Cosby Jr. / USA TODAY NETWORK via Imagn Image
PLAYING
DeBoer - Main
PLAYING
DeBoer - E-Room
PLAYING
Tim Keenan III
PLAYING
Deontae Lawson
PLAYING
Kadyn Proctor
PLAYING
Lebby - Main
PLAYING
Lebby - E-Room
PLAYING
Blake Shapen
PLAYING
Brenen Thompson
PLAYING
Isaac Smith
PLAYING
Napier - Main
PLAYING
Napier - E-Room
PLAYING
Caleb Banks
PLAYING
DJ Lagway
PLAYING
Jake Slaughter
PLAYING
Venables - Main
PLAYING
Venables - E-Room
PLAYING
John Mateer
PLAYING
Robert Spears-Jennings
PLAYING
R Mason Thomas

Press Conference video courtesy of the Southeastern Conference

Wednesday at SEC Media Days brings representatives from Alabama, Mississippi State, Florida and Oklahoma to the College Football Hall of Fame. Each head coach and three player representatives for each school took to the stage on Day 3 in Atlanta.

Discuss
Tags
Press Conferences Brent Venables SEC Media Days Billy Napier Jeff Lebby Kalen DeBoer DJ Lagway Jake Slaughter Blake Shapen Caleb Banks Deontae Lawson Isaac Smith
Show All
Brenen Thompson John Mateer Tim Keenan III Kadyn Proctor Robert Spears-Jennings R Mason Thomas SEC Media Days 2025 Football Oklahoma Mississippi State Florida Alabama 2025
SPONSORED BY
La Caza Tequila
More Football
See All →
Marcel Reed attributes his calm demeanor to his competitiveness
By Billy Liucci
Pick 'Em & Rip 'Em sponsored by PrizePicks: Week 4
By Matthew Dawson
B-Team: We Learned Wednesday, a soap opera in Gainesville & more
By Ryan Brauninger
FTM, Ep. 80: Cody Campbell vs. the SCORE Act, early coach firings & more
By FollowTheMoney
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.